Ritchie C

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (6)

Title : Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer's Disease (NorAD): study protocol for a randomised clinical trial and COVID-19 amendments - Hoang_2022_Trials_23_623
Author(s) : Hoang K , Watt H , Golemme M , Perry RJ , Ritchie C , Wilson D , Pickett J , Fox C , Howard R , Malhotra PA
Ref : Trials , 23 :623 , 2022
Abstract : Hoang_2022_Trials_23_623
ESTHER : Hoang_2022_Trials_23_623
PubMedSearch : Hoang_2022_Trials_23_623
PubMedID: 35915506

Title : Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology - Hampel_2018_J.Alzheimers.Dis_64_S47
Author(s) : Hampel H , Toschi N , Babiloni C , Baldacci F , Black KL , Bokde ALW , Bun RS , Cacciola F , Cavedo E , Chiesa PA , Colliot O , Coman CM , Dubois B , Duggento A , Durrleman S , Ferretti MT , George N , Genthon R , Habert MO , Herholz K , Koronyo Y , Koronyo-Hamaoui M , Lamari F , Langevin T , Lehericy S , Lorenceau J , Neri C , Nistico R , Nyasse-Messene F , Ritchie C , Rossi S , Santarnecchi E , Sporns O , Verdooner SR , Vergallo A , Villain N , Younesi E , Garaci F , Lista S
Ref : J Alzheimers Dis , 64 :S47 , 2018
Abstract : Hampel_2018_J.Alzheimers.Dis_64_S47
ESTHER : Hampel_2018_J.Alzheimers.Dis_64_S47
PubMedSearch : Hampel_2018_J.Alzheimers.Dis_64_S47
PubMedID: 29562524

Title : Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology - O'Brien_2016_J.Psychopharmacol_31_147
Author(s) : O'Brien JT , Holmes C , Jones M , Jones R , Livingston G , McKeith I , Mittler P , Passmore P , Ritchie C , Robinson L , Sampson EL , Taylor JP , Thomas A , Burns A
Ref : J Psychopharmacol , 31 :147 , 2016
Abstract : O'Brien_2016_J.Psychopharmacol_31_147
ESTHER : O'Brien_2016_J.Psychopharmacol_31_147
PubMedSearch : O'Brien_2016_J.Psychopharmacol_31_147
PubMedID: 28103749

Title : Donepezil and memantine for moderate-to-severe Alzheimer's disease - Howard_2012_N.Engl.J.Med_366_893
Author(s) : Howard R , McShane R , Lindesay J , Ritchie C , Baldwin A , Barber R , Burns A , Dening T , Findlay D , Holmes C , Hughes A , Jacoby R , Jones R , McKeith I , Macharouthu A , O'Brien J , Passmore P , Sheehan B , Juszczak E , Katona C , Hills R , Knapp M , Ballard C , Brown R , Banerjee S , Onions C , Griffin M , Adams J , Gray R , Johnson T , Bentham P , Phillips P
Ref : N Engl J Med , 366 :893 , 2012
Abstract : Howard_2012_N.Engl.J.Med_366_893
ESTHER : Howard_2012_N.Engl.J.Med_366_893
PubMedSearch : Howard_2012_N.Engl.J.Med_366_893
PubMedID: 22397651

Title : DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT - Jones_2009_Trials_10_57
Author(s) : Jones R , Sheehan B , Phillips P , Juszczak E , Adams J , Baldwin A , Ballard C , Banerjee S , Barber B , Bentham P , Brown R , Burns A , Dening T , Findlay D , Gray R , Griffin M , Holmes C , Hughes A , Jacoby R , Johnson T , Knapp M , Lindesay J , McKeith I , McShane R , Macharouthu A , O'Brien J , Onions C , Passmore P , Raftery J , Ritchie C , Howard R
Ref : Trials , 10 :57 , 2009
Abstract : Jones_2009_Trials_10_57
ESTHER : Jones_2009_Trials_10_57
PubMedSearch : Jones_2009_Trials_10_57
PubMedID: 19630974

Title : Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology - Burns_2006_J.Psychopharmacol_20_732
Author(s) : Burns A , O'Brien J , Auriacombe S , Ballard C , Broich K , Bullock R , Feldman H , Ford G , Knapp M , McCaddon A , Iliffe S , Jacova C , Jones R , Lennon S , McKeith I , Orgogozo JM , Purandare N , Richardson M , Ritchie C , Thomas A , Warner J , Wilcock G , Wilkinson D
Ref : J Psychopharmacol , 20 :732 , 2006
Abstract : Burns_2006_J.Psychopharmacol_20_732
ESTHER : Burns_2006_J.Psychopharmacol_20_732
PubMedSearch : Burns_2006_J.Psychopharmacol_20_732
PubMedID: 17060346